LA JOLLA—On Saturday, August 17, the Salk Institute will celebrate 28 years of Symphony at Salk, its premier annual concert under the stars. The unforgettable night will feature a performance by the San Diego Symphony with special guest artists David Foster, 16-time Grammy Award®-winning musician, composer, and producer, and Katharine McPhee, acclaimed singer and television/Broadway star.
The unique experience includes a champagne reception and gourmet dinner followed by an immersive, intimate concert, all set in the Institute’s courtyard with stunning views over the Pacific Ocean. Attendees will be surrounded by Louis Kahn’s masterwork of modern architecture lit with images of science and art.
“Symphony at Salk is not just an event,” Salk President Gerald Joyce says. “It’s a celebration where we open our iconic campus and bring together top leaders in science, philanthropy, government, media, and industry to connect and enrich our understanding of the world.”
The event supports the Salk Institute’s wide-ranging scientific inquiries, which have yielded more than 60 years of life-changing discoveries. The Institute, an independent nonprofit, seeks to understand the foundations of biology and address pressing global challenges such as cancer, aging, and climate change.
Sponsorships and individual tickets are available now at www.salk.edu/symphony. For more information, please call 858-597-0657.
Office of Communications
Tel: (858) 453-4100
press@salk.edu
Unlocking the secrets of life itself is the driving force behind the Salk Institute. Our team of world-class, award-winning scientists pushes the boundaries of knowledge in areas such as neuroscience, cancer research, aging, immunobiology, plant biology, computational biology and more. Founded by Jonas Salk, developer of the first safe and effective polio vaccine, the Institute is an independent, nonprofit research organization and architectural landmark: small by choice, intimate by nature, and fearless in the face of any challenge.
Your partnership allows our scientists to accelerate the pace of high-risk, high-reward discoveries that have the potential to benefit the health of all humanity-be it cancer, Alzheimer’s disease, climate change, infectious diseases or more.
